{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:20Z","timestamp":1791404540431,"version":"4.3.3"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hpb.2024.04.003","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T07:09:42Z","timestamp":1713856182000},"page":"938-948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Benjamin J.","family":"Van Treeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5109-907X","authenticated-orcid":false,"given":"Maria C.","family":"Olave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofic","family":"Mounajjed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4259-1158","authenticated-orcid":false,"given":"Michael J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-6945","authenticated-orcid":false,"given":"Carin Y.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2709-3003","authenticated-orcid":false,"given":"Sumera I.","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6104-6489","authenticated-orcid":false,"given":"Nguyen H.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn A.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mahipal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-4867","authenticated-orcid":false,"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2024.04.003_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2024.04.003_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2024.04.003_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2024.04.003_bib4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in olmsted county, Minnesota, 1976-2008","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hpb.2024.04.003_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COC.0000000000000861","article-title":"Efficacy and safety of gemcitabine plus cisplatin as potential preoperative chemotherapy in locally advanced intrahepatic, perihilar, and mid-cholangiocarcinoma: a retrospective cohort study","volume":"44","author":"Nooijen","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.hpb.2024.04.003_bib6","doi-asserted-by":"crossref","first-page":"S1093","DOI":"10.1245\/s10434-015-4768-9","article-title":"Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery","volume":"22","author":"Kato","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib7","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s00268-018-4558-1","article-title":"Chemoradiotherapy for initially unresectable locally advanced cholangiocarcinoma","volume":"42","author":"Sumiyoshi","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2024.04.003_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2024.04.003_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib10","article-title":"Chemotherapy for biliary tract cancer in 2021","volume":"10","author":"Sasaki","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hpb.2024.04.003_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"105","author":"Le Roy","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2024.04.003_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2024.04.003_bib13","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1245\/s10434-023-13809-5","article-title":"NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma","volume":"30","author":"Maithel","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/liv.15641","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: an early exploratory analysis of real-world data","volume":"43","author":"Rimini","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.hpb.2024.04.003_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1245\/s10434-012-2312-8","article-title":"Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study","volume":"20","author":"Kato","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib16","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ejso.2019.03.023","article-title":"Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis","volume":"45","author":"Yadav","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0000000000000738","article-title":"Validation of a proposed tumor regression grading scheme for pancreatic ductal adenocarcinoma after neoadjuvant therapy as a prognostic indicator for survival","volume":"40","author":"Lee","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.hpb.2024.04.003_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4251\/wjgo.v14.i3.607","article-title":"Pathological, molecular, and clinical characteristics of cholangiocarcinoma: a comprehensive review","volume":"14","author":"Vij","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib19","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","article-title":"Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification","volume":"59","author":"Tyson","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hpb.2024.04.003_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1245\/s10434-019-07873-z","article-title":"Advances in the diagnosis and treatment of patients with intrahepatic cholangiocarcinoma","volume":"27","author":"Ejaz","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib21","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1245\/s10434-020-08621-4","article-title":"The landmark series: intrahepatic cholangiocarcinoma","volume":"27","author":"Cloyd","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2024.04.003_bib22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.amjsurg.2021.02.029","article-title":"Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma","volume":"221","author":"Sutton","year":"2021","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2024.04.003_bib23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/HEP.0000000000000046","article-title":"Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial","volume":"77","author":"Jeong","year":"2023","journal-title":"Hepatology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24012590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24012590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:03:08Z","timestamp":1751371388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X24012590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1365182X24012590"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2024.04.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2024.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}